New Key Statistics Module, Z-Score and F-Score
NAS:APLS Key Ratios
| Market Cap $ M | 4,481.00 |
| Enterprise Value $ M | 4,785.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 192.57 |
| Price/Book | 17.66 |
| Price/Sales | 7.46 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 628.00 |
| EPS (TTM) $ | -2.74 |
| Beneish M-Score | 11.12 |
| 10-y EBITDA Growth Rate % | -33.90 |
| 5-y EBITDA Growth Rate % | -13.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -15.96 |
| EV-to-EBITDA | -16.04 |
| PEG | -- |
| Shares Outstanding M | 121.77 |
| Net Margin (%) | -52.94 |
| Operating Margin % | -49.80 |
| Pre-tax Margin (%) | -52.63 |
| Quick Ratio | 4.18 |
| Current Ratio | 5.08 |
| ROA % (ttm) | -39.08 |
| ROE % (ttm) | -127.72 |
| ROIC % (ttm) | -107.81 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.34 |
APLS Number of Guru Trades
APLS Volume of Guru Trades
Gurus Latest Trades with NAS:APLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:APLS is held by these investors
Total 2
Apellis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:APLS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers